A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.
about
Applying linear and non-linear methods for parallel prediction of volume of distribution and fraction of unbound drugInhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic deathSevere falciparum malaria. World Health Organization, Communicable Diseases ClusterCombination therapy for autoimmune diseases: the rheumatoid arthritis model.Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques.Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.Bioavailability of hydroxychloroquine tablets in healthy volunteers.Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit.Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases.Optimizing the use of existing therapies in lupus.Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects.Distribution of hydroxychloroquine in lymphoid tissue in a rabbit model for HIV infectionComplement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.Development and Validation of Reversed-Phase High Performance Liquid Chromatographic Method for Hydroxychloroquine Sulphate.Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.Stereoselective disposition of hydroxychloroquine and its metabolite in rats.Blood concentrations are better predictors of chioroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration/effect relationships.Hematologic disposition of hydroxychloroquine enantiomers.Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate.Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate.Stereoselective distribution of hydroxychloroquine in the rabbit following single and multiple oral doses of the racemate and the separate enantiomers.Comparative study of the pharmacokinetics of MTX in juvenile idiopathic arthritis patients receiving long-term MTX monotherapy or MTX plus chloroquine.Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation.Occasional Series: Lupus Around the World Systemic Lupus Erythematosus Research in the Asia-Pacific Region: A co-ordinated and co-operative approach
P2860
Q28534159-EFD13527-32CA-4783-8A6E-5B188EDD86D4Q28537581-42054E0A-6B29-4F01-AC3A-A648C6960DAFQ29614923-08F1EC8E-D86F-46A6-B5AB-AED46178389DQ34309751-AD0EFAC1-650D-470E-A74F-A3B8AF3ED579Q34345489-EF5C4648-6B6D-4C3B-A4FD-F75FB6C7605EQ34345622-3AB1BBBC-295C-4147-BCEE-5968E2D6A1E1Q34372977-6826BCFF-DFC7-4EE5-8254-6F3880407CCCQ34397314-47C464FB-5BD3-4602-A230-162DD5F7366CQ34604474-49ED47EE-51CC-437F-BFCD-1676CE92C5B7Q38285841-82CADC1A-30E9-4379-8AB5-01AA34617CF5Q38425824-FF4C5713-17BD-4BCA-A037-D0460AAC4ABEQ41898692-997FA56B-5FED-4DDD-9241-6B134E86B7BAQ41907478-02600BAE-94E7-44FA-9F57-1DB2EA8AF40FQ41915133-41A0B73C-8642-49D7-ACBE-6CC555C151E5Q41915917-114B63AB-9DE6-470F-8C29-F52F2AF5AE68Q41917273-1342C06E-1421-4DA5-B86C-083C1BB05374Q41924609-6802F739-0F37-4FA7-AFE4-EE94295F84F7Q41926759-1E93D73B-8601-4A9F-BFC2-D5C280C5ABDBQ41933852-B6CC2AB5-E47C-41E0-873D-94AD8F096868Q41934443-E4278453-6F56-4C7E-BEF5-ADC1DC264DE0Q41934460-888C50AE-5FCC-4055-A69D-672A8798EC93Q41936242-2B150369-F0AB-49E7-87FB-47166138B83AQ41936248-7B9114B2-542A-418B-8D6E-A4342E68D7CEQ41936265-91891B06-739C-488B-8D53-D88EB2AD1E1AQ41941902-88C9CB7B-7697-42A4-85B9-C33A260F21F4Q50036781-C92A75C4-525C-413D-926D-5D692BF71F8EQ56453393-3DCDAA94-1855-42F1-A678-72C5937DBC40
P2860
A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.
description
1988 nî lūn-bûn
@nan
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
A dose-ranging study of the ph ...... tration to healthy volunteers.
@ast
A dose-ranging study of the ph ...... tration to healthy volunteers.
@en
A dose-ranging study of the ph ...... tration to healthy volunteers.
@nl
type
label
A dose-ranging study of the ph ...... tration to healthy volunteers.
@ast
A dose-ranging study of the ph ...... tration to healthy volunteers.
@en
A dose-ranging study of the ph ...... tration to healthy volunteers.
@nl
prefLabel
A dose-ranging study of the ph ...... tration to healthy volunteers.
@ast
A dose-ranging study of the ph ...... tration to healthy volunteers.
@en
A dose-ranging study of the ph ...... tration to healthy volunteers.
@nl
P2093
P2860
P1476
A dose-ranging study of the ph ...... tration to healthy volunteers.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1988.TB05281.X
P407
P577
1988-09-01T00:00:00Z